Responsibilities:
- Facilitate and drive cross-functional Asset Strategy Team effectiveness by translating interconnected strategies into asset-level direction and execution aligned to enterprise and therapeutic/disease objectives.
- Proactively identify, communicate, and manage asset/disease risks and mitigation plans; ensure timely, accurate reporting and support development of timelines with planning.
- Act as the asset โCOO,โ serving as strategic thought partner by synthesizing cross-functional inputs into aligned decisions and actions.
- Enable the Asset Team by optimizing team performance, streamlining communications, and developing strategic narratives for governance forums.
- Coach/mentor Deliverable Team PMs (DTPMs) and Project Planners; build capability and consistency in PM practices.
- Translate strategies into integrated evidence plans across sub-teams and governance.
- Partner to ensure strategy-linked timelines, milestones, reporting, and portfolio tradeoff discussions using scenario analysis/analytics.
- Prepare materials and strategic storyboards for strategy-focused governance reviews.
- Serve as โsource of truthโ for the asset across timelines, deliverables, budgets, and cross-functional connectivity.
Qualifications:
- Bachelorโs degree (scientific, business, or technical preferred).
- 4โ6+ years in pharma/biotech across R&D, commercial, project management, or operations; expertise in one or more therapeutic areas.
- 3+ years supporting cross-functional teams in core function (Program Management, Commercial, Development, Regulatory, Operations).
- Demonstrated strategic thinking, leadership, and strategic communication; strong written/verbal skills.
- Demonstrated knowledge of pharma program management.
- Preferred: late-stage drug development experience (launch team).
- Experience with global teams.
Benefits (if applicable): paid time off, medical/dental/vision, 401(k); eligibility for long-term incentive programs.